FlutiformTM HFA-MDI FlutiformTM HFA-MDI is a fixed-dose combination of formoterol and the inhaled steroid fluticasone in a metered dose inhaler ('MDI'). ...
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis: the CAFFS Trial: a randomized controlled trial. JAMA. ...
The Company has eleven approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by ...
The Company has eleven approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by ...